Bis(3-methoxyphenyl)amine

Catalog No.: 
ACZBGR417
CAS No.: 
92248-06-1
Molecular Formula: 
C14H15NO2
Molecular Weight: 
229.28
Bis(3-methoxyphenyl)amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%
5g95%
25g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBis(3-methoxyphenyl)amine
IUPAC Namebis(3-methoxyphenyl)amine
MDL No.MFCD23703137
Molecular FormulaC14H15NO2
Molecular Weight229.28
SMILESCOC1=CC(NC2=CC=CC(OC)=C2)=CC=C1
InChI KeySUTJWELGLJHXGI-UHFFFAOYSA-N
Synonymbis(3-Methoxyphenyl)aMine;Benzenamine, 3-methoxy-N-(3-methoxyphenyl)-;3-Methoxy-N-(3-methoxyphenyl)aniline;bis(3-Methoxyphenyl)aMine ISO 9001:2015 REACH
CAS No.92248-06-1
PubChem CID15835905

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACZBGR417 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLNDA618 route compound structure diagram
    ACLNDA6182398-37-0In Stock
  2. Plus
  3. ACJXEI853 route compound structure diagram
    ACJXEI85327191-09-9In Stock
  4. Then
  5. ACZBGR417 route product structure diagram
    ACZBGR41792248-06-1In Stock
Inquiry

2. ACZBGR417 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXEI853 route compound structure diagram
    ACJXEI85327191-09-9In Stock
  4. Then
  5. ACZBGR417 route product structure diagram
    ACZBGR41792248-06-1In Stock
Inquiry

3. ACZBGR417 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLZOH286 route compound structure diagram
    ACLZOH28610365-98-7In Stock
  2. Plus
  3. ACJXEI853 route compound structure diagram
    ACJXEI85327191-09-9In Stock
  4. Then
  5. ACZBGR417 route product structure diagram
    ACZBGR41792248-06-1In Stock
Inquiry

Comments (0)